REVANCE THERAPEUTICS INC - NOTE 1.750% 2/1

Historical Portfolio Holders from Q1 2021 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Debt / NOTE 1.750% 2/1
Principal, excl. options Q3 2024
198M
Holdings value Q3 2024
$177M
Value change Q3 2024
+$6.71M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
22
Number of buys Q3 2024
12
Number of sells Q3 2024
-15
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Principal Value Change Price Investors
2024 Q3 $198M $177M +$6.71M $0.85 22
2024 Q2 $212M $139M -$15.5M $0.66 21
2024 Q1 $232M $202M -$23.1B $0.73 22
2023 Q4 $265M $201M +$13.1M $0.76 23
2023 Q3 $246M $199M +$8.92M $0.80 29
2023 Q2 $231M $244M -$12.9M $1.06 27
2023 Q1 $240M $300M +$36.8M $1.23 27
2022 Q4 $234M $217M -$36.4M $0.92 23
2022 Q3 $308M $337M -$6.83M $1.09 27
2022 Q2 $273M $227M +$15.5M $0.82 18
2022 Q1 $249M $240M -$22M $0.94 19
2021 Q4 $253M $226M -$17.4M $0.88 19
2021 Q3 $282M $325M +$23.1M $1.15 21
2021 Q2 $262M $307M +$5.15M $1.17 25
2021 Q1 $266M $299M +$299M $1.12 27